Forward PE Ratio: N/A
The forward PE ratio is N/A as of Thursday, July 9, 2026.
Forward PE Ratio (N/A) = Close Price ($35.45) / Consensus Forward EPS ($-0.12)
HIMS Forward PE Ratio Metrics
FORWARD PE RATIO
N/A
HIMS Competitors' Forward PE Ratio
Hims & Hers Health, Inc.
Market Cap
$7.91B
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Hims & Hers Health, Inc. (HIMS) | $7.91B | N/A |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.04B | 31.40 |
| Oscar Health, Inc. (OSCR)vs › | $8.09B | 29.55 |
| Henry Schein, Inc. (HSIC)vs › | $9.55B | 15.56 |
| Universal Health Services, Inc. (UHS)vs › | $9.72B | 6.66 |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | 7.65 |
| Tempus AI, Inc. (TEM)vs › | $10.73B | N/A |
| Insulet Corp. (PODD)vs › | $10.96B | 24.29 |
| Bio-Techne Corporation (TECH)vs › | $11.14B | 36.89 |
| Charles River Laboratories International, Inc. (CRL)vs › | $11.25B | 20.18 |
Trailing vs Forward
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus next-FY EPS
Forward P/E by Fiscal Year
View All Analyst EstimatesAt today's $35.45 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-0.12 | $-0.12 – $-0.12 | 2 | n/m |
| 2027-12-31 | $0.47 | $0.29 – $0.64 | 3 | 76.0x |
| 2028-12-31 | $0.78 | $0.77 – $0.79 | 1 | 45.4x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
Forward PE Ratio Formula & Definition
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Related Metrics
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Andrew Dudum